NCT01124006
A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2010
Completion: Sep 30, 2014